Naringenin, a natural compound found in citrus fruits, reversed brain problems in mice with fatty liver disease, improving memory, reducing anxiety, and decreasing depression-like behavior within 4 weeks of treatment. According to Gram Research analysis of this 2026 study, the compound worked by protecting brain cells from damage and restoring a key brain-growth protein. However, this research was conducted in mice, so human clinical trials are needed before naringenin can be recommended as a treatment.
A new study found that naringenin, a natural compound found in citrus fruits like grapefruits and oranges, may help protect the brain from damage caused by non-alcoholic fatty liver disease (NASH). Researchers gave mice with liver disease either naringenin or a placebo for 4 weeks and tested their memory, anxiety levels, and mood. According to Gram Research analysis, the mice that received naringenin showed significant improvements in all three areas, performed better on memory tests, and showed less anxiety and depression-like behavior. The compound appeared to work by reducing harmful cell death in the brain and boosting a key brain-growth protein. While these results are promising, the research was done in mice, so scientists need to test whether naringenin works the same way in humans.
Key Statistics
A 2026 animal study published in Nutritional Neuroscience found that naringenin treatment for 4 weeks reversed memory impairment in mice with fatty liver disease, as measured by improved performance on novel object recognition tests.
In the same 2026 study of 32 mice, naringenin reduced anxiety-like behavior in two separate tests (open field and elevated plus maze) and decreased depression-like behavior in the forced swim test compared to untreated mice with liver disease.
The 2026 research showed that naringenin partially restored BDNF (brain-derived neurotrophic factor), a critical protein for learning and memory that was suppressed by the fatty liver disease, suggesting this mechanism may explain the cognitive improvements observed.
The Quick Take
- What they studied: Whether a natural compound from citrus fruits called naringenin could help reverse brain problems (like memory loss, anxiety, and depression) caused by a fatty liver disease in mice.
- Who participated: Male laboratory mice (32 total, split into groups) that were fed a special diet designed to cause fatty liver disease similar to what happens in humans.
- Key finding: Mice treated with naringenin for 4 weeks showed major improvements: better memory on recognition tests, less anxiety in open spaces, and less depression-like behavior compared to untreated mice with the same liver disease.
- What it means for you: This research suggests that citrus flavonoids might one day help people with fatty liver disease avoid brain problems like memory loss and depression. However, this is early-stage research in animals—much more testing is needed before doctors could recommend it for humans. Don’t start taking naringenin supplements based on this study alone.
The Research Details
Scientists created a mouse model of fatty liver disease by feeding mice a special diet lacking two nutrients (methionine and choline) for 8 weeks. This diet causes the same type of liver damage seen in humans with NASH. During the last 4 weeks of the diet, half the mice received daily injections of naringenin (a flavonoid extracted from citrus), while the other half received a placebo injection. The researchers then tested the mice’s brain function using three standard behavioral tests: a memory test (novel object recognition), an anxiety test (open field and elevated plus maze), and a depression test (forced swim test). After behavioral testing, they examined the mice’s brain tissue to understand how naringenin worked at the cellular level, looking at genes and proteins involved in cell death and brain growth.
This study design is important because it mimics the real-world problem: people with fatty liver disease often develop brain problems alongside their liver disease. By testing naringenin in a controlled animal model, researchers could isolate whether the compound specifically protects the brain, and they could examine the exact biological mechanisms. The 4-week treatment window is realistic for testing whether a compound can reverse existing damage rather than just prevent it.
This is a controlled laboratory study with clear treatment and control groups, which is good for establishing cause-and-effect. The sample size (8 mice per group) is standard for preliminary animal research. The study used multiple behavioral tests rather than relying on just one measure, which strengthens confidence in the findings. However, animal studies don’t always translate to humans—mice metabolize compounds differently than people do, and their brains respond differently to treatment. The study was published in a peer-reviewed journal (Nutritional Neuroscience), meaning other experts reviewed it before publication. The authors appropriately note that clinical trials in humans are needed before any medical recommendations can be made.
What the Results Show
Naringenin treatment produced three major improvements in brain function. First, mice treated with naringenin performed significantly better on a memory test (novel object recognition task) compared to untreated mice with fatty liver disease, suggesting the compound reversed memory loss. Second, naringenin reduced anxiety-like behavior in two different anxiety tests—mice spent more time in open areas (open field test) and on exposed platforms (elevated plus maze) when treated, indicating less fear and anxiety. Third, in a depression test (forced swim test), naringenin-treated mice showed less ‘giving up’ behavior and more active swimming, suggesting antidepressant-like effects. These behavioral improvements occurred after just 4 weeks of treatment, even though the mice had been on the liver-damaging diet for 8 weeks total.
At the cellular level, naringenin appeared to work by protecting brain cells from dying. In untreated mice with fatty liver disease, the researchers found an imbalance in proteins that control cell death—too much of a ‘death-promoting’ protein (Bax) and too little of a ‘survival-promoting’ protein (Bcl2). Naringenin treatment restored this balance toward normal levels. Additionally, the fatty liver disease had suppressed a critical brain-growth protein called BDNF (brain-derived neurotrophic factor), which is essential for learning and memory. Naringenin partially restored BDNF levels, though it didn’t fully normalize another related protein (NTRK2). This suggests BDNF restoration may be one key mechanism behind naringenin’s protective effects.
Previous research has shown that naringenin has anti-inflammatory and antioxidant properties, and some studies suggested it might protect nerve cells. This study is novel because it’s the first to test naringenin specifically in the context of brain problems caused by fatty liver disease. The findings align with earlier research showing that flavonoids (plant compounds in fruits and vegetables) can reduce inflammation and support brain health. However, most prior work tested naringenin in simpler systems or for different conditions, so this study extends our understanding to a more complex, disease-relevant model.
The most important limitation is that this research was conducted in mice, not humans. Mice have different metabolism, brain chemistry, and disease progression than people, so results may not translate directly. The study used only male mice, so it’s unclear whether naringenin would work the same way in females. The sample size (8 mice per group) is small, which is typical for animal studies but means results should be confirmed in larger studies. The treatment duration was only 4 weeks, so we don’t know if benefits persist longer or if there are long-term side effects. The study didn’t test different doses or compare naringenin to other potential treatments. Finally, the researchers used injections rather than oral administration, which is how humans would take such a compound, so the practical effectiveness in real-world use remains unknown.
The Bottom Line
Based on this animal research, naringenin shows promise as a potential treatment for brain problems related to fatty liver disease, but it is NOT yet ready for human use. Confidence level: LOW for human application (this is early-stage research). If you have fatty liver disease and are experiencing memory problems, anxiety, or depression, talk to your doctor about proven treatments rather than waiting for naringenin. Eating citrus fruits as part of a healthy diet is always reasonable, but don’t expect therapeutic benefits from food sources alone based on this study.
This research is most relevant to: (1) Scientists studying fatty liver disease and brain health, (2) Researchers developing new treatments for NASH, (3) People with fatty liver disease who are interested in emerging therapies. This research should NOT be used by: (1) People self-treating with naringenin supplements, (2) Patients making medical decisions without consulting their doctor, (3) Anyone assuming citrus fruits alone will treat liver or brain disease.
In this mouse study, benefits appeared within 4 weeks of treatment. However, if naringenin ever reaches human trials, it could take 5-10+ years of research before it becomes available as a medical treatment. Don’t expect rapid translation from animal research to clinical practice.
Frequently Asked Questions
Can I take naringenin supplements to treat fatty liver disease and brain problems?
Not yet—this research is only in mice. While naringenin shows promise, human clinical trials haven’t been conducted. Talk to your doctor about proven treatments for fatty liver disease rather than self-treating with supplements based on animal studies.
Does eating citrus fruits provide the same naringenin dose used in this study?
Unlikely. The study used concentrated naringenin injections (50 mg/kg daily), which is much higher than what you’d get from eating citrus. While citrus fruits are healthy, they probably won’t deliver therapeutic doses based on this research.
How long would it take for naringenin to become a human treatment?
If development proceeds, it typically takes 5-10+ years from animal studies to human clinical trials to FDA approval. This research is an early step, so naringenin is years away from being a recommended medical treatment, if it ever reaches that stage.
Why did researchers use mice instead of testing humans directly?
Animal studies are required before human trials for safety and ethical reasons. Mice allow researchers to control variables precisely, examine brain tissue directly, and test whether a compound works before risking human exposure. However, mouse results don’t always translate to humans.
What should I do if I have fatty liver disease and depression or memory problems?
See your doctor about evidence-based treatments for both conditions. Proven approaches include weight loss, reducing alcohol, managing blood sugar, and medications for depression. Don’t wait for experimental compounds like naringenin when effective treatments exist today.
Want to Apply This Research?
- Users with fatty liver disease could track three brain-health markers weekly: (1) Memory performance using a simple recall game, (2) Anxiety levels using a 1-10 scale during daily activities, (3) Mood/depression using a standard screening question. This creates a baseline to discuss with their doctor and allows monitoring if they eventually try any interventions.
- While naringenin supplements aren’t yet recommended, users can increase dietary flavonoids by eating more citrus fruits (grapefruits, oranges, lemons), which contain naringenin naturally. The app could suggest: ‘Add one citrus fruit to your daily diet’ and track consumption. Pair this with proven liver-health behaviors: reducing alcohol, maintaining healthy weight, and managing blood sugar.
- Create a ‘Brain & Liver Health’ dashboard tracking: weekly cognitive function (memory games), mood scores, anxiety levels, and dietary flavonoid intake. Set monthly check-ins to review trends and discuss results with healthcare providers. This positions the app as a tool for informed conversations with doctors rather than a treatment platform.
This article describes early-stage animal research and should not be interpreted as medical advice or a recommendation to use naringenin supplements. Naringenin has not been tested in humans for treating fatty liver disease or brain problems. If you have fatty liver disease, neuropsychiatric symptoms, or are considering any new supplement, consult your healthcare provider before making changes. This research is preliminary and requires human clinical trials before any therapeutic claims can be made. Do not self-treat based on animal studies.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.